“ID: 2036 Next-Generation Sequencing to Evaluate Frequency of BCR-ABL1 Kinase Domain Imatinib-Resistance Mutations”. 2017. Biomedical Research and Therapy 4 (S): S67. https://doi.org/10.15419/bmrat.v4iS.275.